Payer and Market Access lead for Psychiatry and Mood disorder products.

• Responsible for development and execution of channel marketing strategy spanning multiple sites-of-care including hospitals, health systems/IDNs, physician practices, ambulatory clinics, and home-health. • Developed customized access strategies, value props, marketing materials and led multiple POA meetings for nationwide portfolio field teams (Academic, Area Business Specialists, and Key Account Managers). • Portfolio team lead for 2017 and 2019 Business Planning process, integrating input across multiple internal stakeholders and distilling down for leadership review and approval of annual budget.• Oversight of departmental budget and team of direct reports

• Directed global commercial and market access strategy for Alzheimer’s disease portfolio, including business planning, launch preparation activities, and budget oversight ($1-2M annually).• Led early (Phase 2) business development and valuation efforts for neuroscience internal assets and licensing/acquisition opportunities. -Core member of deal teams for Janssen licensing agreement with AC-Immune (Dec 2014) and option agreement with Orion Pharmaceuticals (Dec 2013). • Co-lead for global launch activities of a point-of-care diagnostic for the evaluation of antipsychotic medication levels in patients with mental illnesses (Project Indigo). • Global commercial lead for the development of an innovative training tool that accompanies INVEGA TRINZA® to mitigate against potential administration errors and reduce administration-related product quality complaints to less than 1/4500 six months post-launch. • Commercial strategy leader on compound development teams for five clinical-stage programs.

• Directed market and brand development strategy, execution, and business planning for biologic portfolio of assets co-developed with Pfizer, Inc.• Created product brand vision, positioning, logo, buying process, and market segmentation for Ph3 biologic compound in pre-launch development.• Led Alzheimer’s Challenge 2012 open innovation contest focused on a specific unmet need in Alzheimer’s disease that generated over 100 entries and awarded $300,000. • Supervised business intelligence and analytics (market research, forecasting) for strategic business planning cycles.• Budget oversight for market development and brand development pre-launch activities ($3M-$10M annually)• Promoted from Associate Director to Director in August 2012

• Market forecasting for pharmaceutical group services. Focus on HIV and Anti-Bacterial franchises.• Analyzed internal pipeline development, life-cycle strategies, and new business licensing deals to achieve long-term franchise growth objectives.• Collected and integrated market insights from business intelligence and market research studies into actionable forecast models. • Communicated strategic analyses to senior management and international regional operating companies.

• Evaluated competitive landscape and industry dynamics for Ethicon Products and Women’s Health & Urology divisions to identify potential strategic acquisition targets.

• Bench scientist focused on electrophysiologic applications used to study learning & memory pathways in the brain. • Established in-house electrophysiology techniques to assess safety risk (QT prolongation) in early-stage compounds.• Optimized data acquisition methods enabling a 150% improvement in throughput and elimination of a process bottleneck, which yielded a 75% reduction in operating costs.• Presented critical corporate information on preclinical scientific achievements and common safety-signal/adverse event data during VC funding, partner licensing, and initial public offering (IPO) pitches.

• Academic bench scientist responsible for designing, performing, and reporting experiments on hearing and balance. • Co-authored four hearing & balance research papers in peer-reviewed academic journals (Science, J. Neurosci) while completing requirements for a Master of Science degree.